Neurotechnology development in 2025 showed a shift from exploratory demonstration toward systems engineered around specific clinical and research uses. Across brain–computer interfaces, neuromodulation, diagnostics, and …
Read More
Tempus has introduced Paige Predict, a new suite of AI-based digital pathology tools that analyze standard hematoxylin and eosin (H&E) stained tissue slides to estimate …
Read More
OpenEvidence, a specialized AI-powered medical search engine, has raised $250 million in a Series D financing round led by Thrive Capital and DST Global, valuing …
Read More
BioAge Labs will expand clinical development of its oral brain-penetrant small molecule NLRP3 inhibitor, BGE-102, into ophthalmology, initiating a Phase 1b/2a proof-of-concept trial in patients …
Read More
Insilico Medicine and Hygtia Therapeutics have entered a global co-development and licensing agreement for ISM8969, an orally available, blood-brain barrier–penetrant NLRP3 inhibitor intended for central …
Read More
London-based Isomorphic Labs broke the news with yet another pharmaceutical partnership, announcing a new research collaboration with Johnson & Johnson’s Janssen Biotech unit aimed at …
Read More
